GW Research Limited
Records under this name other than patents GW Research Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,205,063 | Cannabinoid-Containing Plant Extracts as Neuroprotective Agents Formerly held In force · High confidence | In force | High confidence | |
| US 11,963,937 | Use of Cannabinoids in the Treatment of Epilepsy Formerly held In force · High confidence | In force | High confidence | |
| US 8,673,368 | Cannabinoid-Containing Plant Extracts as Neuroprotective Agents Formerly held In force · High confidence | In force | High confidence | |
| US 12,357,586 | Use of the Phytocannabinoid Cannabidiol (CBD) in Combination with a Standard Anti-Epileptic Drug (SAED) in the Treatment of Epilepsy Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,220,005 | Synergistic Therapies of Cannabidiol with Hypothermia for Neuroprotection Formerly held In force · High confidence | In force | High confidence | |
| US 9,675,579 | Tetrahydrocannabivarin for Use in the Treatment of Nausea and Vomiting Formerly held In force · High confidence | In force | High confidence | |
| US 10,098,867 | The Use of Phytocannabinoids in the Treatment of Ovarian Carcinoma Formerly held In force · High confidence | In force | High confidence | |
| US 9,474,726 | Use of Cannabinoids in the Treatment of Epilepsy Formerly held In force · High confidence | In force | High confidence | |
| US 9,949,936 | Use of Cannabinoids in the Treatment of Epilepsy Formerly held In force · High confidence | In force | High confidence | |
| US 9,949,937 | Use of Cannabinoids in the Treatment of Epilepsy Formerly held In force · High confidence | In force | High confidence |